Furthermore, blocking the activation of STAT3 by Stattic, a STAT3 inhibitor, could inhibit the viability of ESCC cells and down-regulate the expression of VEGF and Cyclin D1. This evidence concerns the gene CCND1 and esophageal squamous cell carcinoma.